Moore Capital Management’s Entrada Therapeutics TRDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$706K Hold
2025
Q1
$949K Hold
2024
Q4
$1.82M Hold
2024
Q3
$1.68M Hold
2024
Q2
$1.5M Hold
2024
Q1
$1.49M Hold
2023
Q4
$1.58M Hold
2023
Q3
$1.66M Hold
2023
Q2
$1.59M Hold
2023
Q1
$1.52M Hold
2022
Q4
$1.42M Hold
2022
Q3
$1.66M Hold
2022
Q2
$1.28M Hold
2022
Q1
$986K Hold
2021
Q4
$1.8M Buy